Literature DB >> 21110196

A slightly elevated level of N-terminal pro-brain natriuretic peptide can predict coronary artery disease in a population with normal left ventricular function.

Nobutaka Ikeda1, Masato Nakamura, Yoshiyuki Yazaki, Tsuyoshi Ono, Masaya Yamamoto, Shingo Ito, Itaru Yokouchi, Suguru Yajima, Raisuke Iijima, Hidehiko Hara, Takuro Takagi, Hisao Hara, Toshiyuki Asahara, Hideyuki Sakai, Kaoru Sugi.   

Abstract

The prognostic and diagnostic values of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) in ischemic heart disease have already been investigated in many previous studies. Although NT-pro-BNP is affected by many factors, these previous studies did not strictly exclude them. This study included 110 patients who received coronary arteriography between November 2007 and September 2009. Excluded from the study were those patients who had clinical symptoms of heart failure, asynergy by echocardiography or left ventriculography (LVG), atrial fibrillation, prior myocardial infarction, valvular disease, lung disease, anemia or renal dysfunction. We compared the laboratory data, LVG and early transmitral-to-early diastolic annular velocity ratio (E/E (a)) in echocardiography between the group with coronary stenosis and the group without it. NT-pro-BNP and the low-density lipoprotein/high-density lipoprotein ratio (LDL/HDL) independently associated with the presence of coronary artery stenosis (odds ratio of NT-pro-BNP, each 50 pg/ml 2.367, 95% confidence interval 1.302-4.303, p = 0.005). The area under the curve of the receiver-operating characteristic (ROC) curve of NT-pro-BNP, used to predict coronary artery stenosis, was 0.801 (0.719-0.883, p < 0.001). According to the ROC curve, the optimal cut-off level for predicting coronary stenosis was 64.3 pg/ml (sensitivity 82.5%, false-positive 34%). NT-pro-BNP is an attractive supplemental marker to predict the presence of coronary artery stenosis in a population that strictly excluded any affecting factors. In the population without factors affecting NT-pro-BNP, a slight increase suggests the presence of ischemic heart disease. The normal criteria for NT-pro-BNP in the patients undergoing coronary angiography may be much lower than the one currently used.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21110196     DOI: 10.1007/s00380-010-0080-6

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  26 in total

1.  N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes.

Authors:  Torbjørn Omland; Anita Persson; Leong Ng; Russel O'Brien; Thomas Karlsson; Johan Herlitz; Marianne Hartford; Kenneth Caidahl
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

2.  Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease.

Authors:  Enyu Imai; Masaru Horio; Kosaku Nitta; Kunihiro Yamagata; Kunitoshi Iseki; Shigeko Hara; Nobuyuki Ura; Yutaka Kiyohara; Hideki Hirakata; Tsuyoshi Watanabe; Toshiki Moriyama; Yasuhiro Ando; Daiki Inaguma; Ichiei Narita; Hiroyasu Iso; Kenji Wakai; Yoshinari Yasuda; Yusuke Tsukamoto; Sadayoshi Ito; Hirofumi Makino; Akira Hishida; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2007-03-28       Impact factor: 2.801

3.  Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings.

Authors:  Emily Lubien; Anthony DeMaria; Padma Krishnaswamy; Paul Clopton; Jen Koon; Radmila Kazanegra; Nancy Gardetto; Erin Wanner; Alan S Maisel
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

4.  N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.

Authors:  Kirsten Bibbins-Domingo; Reena Gupta; Beeya Na; Alan H B Wu; Nelson B Schiller; Mary A Whooley
Journal:  JAMA       Date:  2007-01-10       Impact factor: 56.272

5.  The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study.

Authors:  Alex Zaphiriou; Stephen Robb; Tarita Murray-Thomas; Gustavo Mendez; Kevin Fox; Theresa McDonagh; Suzanna M C Hardman; Henry J Dargie; Martin R Cowie
Journal:  Eur J Heart Fail       Date:  2005-06       Impact factor: 15.534

6.  N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis.

Authors:  T Wolber; M Maeder; H Rickli; W Riesen; C Binggeli; F Duru; P Ammann
Journal:  Eur J Clin Invest       Date:  2007-01       Impact factor: 4.686

7.  Elevated troponin T on discharge predicts poor outcome of decompensated heart failure.

Authors:  Kimi Koide; Tsutomu Yoshikawa; Yuji Nagatomo; Shun Kohsaka; Toshihisa Anzai; Tomomi Meguro; Satoshi Ogawa
Journal:  Heart Vessels       Date:  2010-05-29       Impact factor: 2.037

8.  N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation.

Authors:  Tomas Jernberg; Mats Stridsberg; Per Venge; Bertil Lindahl
Journal:  J Am Coll Cardiol       Date:  2002-08-07       Impact factor: 24.094

9.  N-terminal pro B-type natriuretic peptide predicts mortality in patients with left ventricular hypertrophy.

Authors:  Santiago Garcia; Muhammad S Akbar; Syed S Ali; Forum Kamdar; Michael Y Tsai; Daniel A Duprez
Journal:  Int J Cardiol       Date:  2009-04-07       Impact factor: 4.164

10.  Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.

Authors:  Conor J McCann; Ben M Glover; Ian B A Menown; Michael J Moore; Jane McEneny; Colum G Owens; Bernie Smith; Peter C Sharpe; Ian S Young; Jennifer A Adgey
Journal:  Am J Cardiol       Date:  2008-10-17       Impact factor: 2.778

View more
  4 in total

1.  N-terminal pro-brain natriuretic peptide could be a marker of subclinical atherosclerosis in patients with type 2 diabetes.

Authors:  Takafumi Senmaru; Michiaki Fukui; Muhei Tanaka; Kazumi Sakabe; Emi Ushigome; Mai Asano; Masahiro Yamazaki; Goji Hasegawa; Naoto Nakamura
Journal:  Heart Vessels       Date:  2012-01-11       Impact factor: 2.037

2.  The autopsy study of 553 cases of sudden cardiac death in Chinese adults.

Authors:  Hongyue Wang; Qingsong Yao; Shaohua Zhu; Guohua Zhang; Zhenyuan Wang; Zhen Li; Rongchao Sun; Changli Lu; Changrong Li; Jielin Pu
Journal:  Heart Vessels       Date:  2013-07-09       Impact factor: 2.037

3.  Hyperthermia by bathing in a hot spring improves cardiovascular functions and reduces the production of inflammatory cytokines in patients with chronic heart failure.

Authors:  Jun-Ichi Oyama; Yoshihiro Kudo; Toyoki Maeda; Koichi Node; Naoki Makino
Journal:  Heart Vessels       Date:  2012-01-11       Impact factor: 2.037

4.  High concentrations of omega-3 fatty acids are associated with the development of atrial fibrillation in the Japanese population.

Authors:  Takeshi Tomita; Takeki Hata; Takahiro Takeuchi; Yasutaka Oguchi; Ayako Okada; Kazunori Aizawa; Megumi Koshikawa; Kyuhachi Otagiri; Hirohiko Motoki; Hiroki Kasai; Atsushi Izawa; Jun Koyama; Minoru Hongo; Uichi Ikeda
Journal:  Heart Vessels       Date:  2012-06-14       Impact factor: 2.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.